提高性结肠炎管理的标准
Fabrizio Fanizzi1, Mariangela Allocca1, Gionata Fiorino2
1Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, Milan, Italy.
Therapeutic advances in gastroenterology
|November 27, 2024
概括
性结肠炎 (UC) 管理正在向个性化,治疗到目标的战略发展. 新的疗法和客观参数旨在改善患者的治疗结果,并控制这种慢性炎症性肠病.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 性结肠炎 (UC) 是一种慢性炎症性肠病,其全球发病率和流行率正在增加.
- 目前的UC管理涉及各种策略,但由于新药的开发和缺乏具体指导方针,仍然存在挑战.
- 转向个人化医疗的转变旨在根据个体患者的个人资料量身定制治疗.
研究的目的:
- 审查当前和新兴的治疗策略来管理性结肠炎 (UC).
- 讨论个性化医学和治疗到目标方法在优化UC治疗中的作用.
- 突出新型分子标和双重向疗法的潜力,以实现UC缓解.
主要方法:
- 关于UC治疗近期进展的综合文献综述.
- 对UC管理的临床,内镜,生化,组织学,超声波和分子参数的分析.
- 评估个性化和治疗到目标策略,包括双重目标治疗.
主要成果:
- 个性化医疗和治疗到目标策略正在成为UC管理的核心.
- 像组织学,超声波和分子标等客观参数可以提高治疗效率.
- 双重向治疗对于耐火性UC病例来说是一个有前途的选择.
结论:
- 优化UC管理需要个性化,针对目标的方法,包括各种客观参数.
- 新兴的疗法和策略旨在改善疾病控制和性结肠炎患者的治疗结果.
- 对新型治疗点和组合疗法的进一步研究对于推进UC护理至关重要.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
120
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
120
Inflammatory Bowel Disease IV: Pharmacological Management
113
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
113
Inflammatory Bowel Disease V: Surgical Management
121
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
121
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
317
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
317
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
96
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
96
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
142
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
142


